Millington Financial Advisors, LLC

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 1924615 NAPERVILLE, IL

Position in SLS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$369,000

+$263,250 QoQ

Shares Held

25,000

0.0% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#100

of 189 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Millington Financial Advisors, LLC holds $3,778,949 across 4 Biotechnology names. SLS ranks #2 (9.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	29,229	$3,313,399
2	SLS	SELLAS Life Sciences Group, Inc. This page	25,000	$369,000
3	HELP	Cybin Inc.	10,000	$66,100
4	GANX	Gain Therapeutics, Inc.	15,000	$30,450

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$369,000	25,000	0.0%	Shares	Sole	2026-08-07
2026-03-31	$105,750	25,000	0.0%	Shares	Sole	2026-05-08
2025-12-31	$94,250	25,000	—	Shares	Sole	2026-02-09
No filing history on record for this holder in this stock.